Beta-Hydroxybutyrate Inhibits Bronchial Smooth Muscle Contraction
Fastiggi, V. A.; Mank, M. M.; Caporizzo, M. A.; Poynter, M. E.
Show abstract
Asthma is a chronic respiratory condition characterized by airway inflammation, remodeling, and hyperresponsiveness to triggers causing airway constriction. Bronchial smooth muscle plays a critical role by narrowing airways, leading to obstruction and breathing difficulties, often exacerbated by mast cell infiltration and histamine release. Whereas current treatments, including bronchodilators, corticosteroids, and biologics provide effective management for most patients, alternative therapies are needed for difficult-to-treat asthma. Recent research highlights the potential of therapeutic ketosis, achieved through dietary interventions or supplementation with exogenous ketones, to reduce airway hyperresponsiveness and inflammation. Ketone bodies, known for providing energy during carbohydrate scarcity, also influence asthma by activating cell-surface receptors and transporters. In vivo, interventions like weight loss and caloric restriction increase ketone body levels, correlating with improved asthma symptoms, reduced oxidative stress, and inflammation. These effects suggest ketone bodies, particularly {beta}-hydroxybutyrate, may play a therapeutic role in mitigating bronchoconstriction and smooth muscle contraction in asthma. We utilize human bronchial smooth muscle cells (in vitro) and mouse precision-cut lung slices (PCLS) (ex vivo) to assess the effects of BHB on histamine-induced bronchoconstriction. Brightfield microscopy showed that BHB reduces contraction in human bronchial smooth muscle cells, an effect involving free fatty acid receptor 3 (FFAR3) activation. Light microscopy of PCLS revealed that BHB inhibits airway narrowing and cellular extrusion, demonstrating its ability to mitigate bronchoconstriction by suppressing smooth muscle contraction. These results implicate bronchial smooth muscle as a cellular target of therapeutic ketosis, an important contributor to the beneficial effects of BHB in preclinical models of asthma. Graphical AbstractIn accordance with journal requirements, a graphical abstract will be submitted if we are invited to revise this manuscript.
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Human pulmonary neuroendocrine cells respond to House dust mite extract with PAR-1 dependent release of CGRP 94%
- The effects of inhaled corticosteroids on healthy airways 93%
- Distribution of ACE2, CD147, cyclophilins, CD26 and other SARS-CoV-2 associated molecules in human tissues and immune cells in health and disease 93%
Similar papers in this journal
Similar papers in this journal
- Therapeutic Targeting of 15-PGDH in Murine Idiopathic Pulmonary Fibrosis 94%
- The ammonia oxidizing bacterium Nitrosomonas eutropha D23 blocks T helper 2 cell polarization via IL-10 mediated interference with dendritic cell activation 93%
- Single-cell analysis identifies distinct CD4+ T cells associated with the pathobiology of pediatric obesity-related asthma 93%
Similar papers in this journal
Similar papers in this journal
- Immunoglobulin M regulates airway hyperresponsiveness independent of T helper 2 allergic inflammation. 94%
- Identification of Paired-related Homeobox Protein 1 as a key mesenchymal transcription factor in Idiopathic Pulmonary Fibrosis 91%
- Loss of adaptive capacity in asthmatics revealed by biomarker fluctuation dynamics on experimental rhinovirus challenge 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.